Peripheral tissues, including intercostal muscle, diaphragm and pancreas of SMA patients treated with onasemnogene also showed abnormal high expression of SMN transcripts, raising concerns similar to those noted with liver (Thomsen et al., 2021). This evidence concerns the gene SMN2 and proximal spinal muscular atrophy.